Trelegy ellipta approval date?

See the DrugPatentWatch profile for Trelegy

When was Trelegy Ellipta first approved?

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) received its initial U.S. FDA approval on September 18, 2017. 1

Was Trelegy approved for the same patients right away (COPD vs. asthma)?

Trelegy’s first FDA approval covered COPD (chronic obstructive pulmonary disease). 1
Later regulatory actions expanded its use to additional indications, including asthma, but the approval date for the original product launch was September 18, 2017. 1

What if I’m looking for the approval date in another country?

Approval dates vary by regulator and indication. The September 18, 2017 date is the initial FDA approval for Trelegy Ellipta in the United States. 1

Source